Medical Weight Loss for Mandan, North Dakota Residents
Mandan, North Dakota residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Mandan through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Mandan Residents Choose New Hope Weight Loss
Since 2020, New Hope Weight Loss has treated more than 5,400 patients from its Costa Mesa, California clinic, and Mandan, North Dakota residents get that same physician-led program by telehealth. Pricing is flat and transparent, with care overseen by Dr. Anjmun Sharma, M.D., and no insurance required to start.
Medical weight loss for Mandan is handled end-to-end online: intake, the $119 physician review with Dr. Sharma, dose titration, and follow-ups, all by secure video, with no drive and no pharmacy line.
Patients across Mandan and the surrounding area connect with Dr. Sharma by secure video, wherever they live in North Dakota. We care for patients throughout downtown Mandan and the Bismarck-Mandan metro on the Missouri River. Compounded semaglutide and tirzepatide ship directly to your door in North Dakota, and a licensed physician reviews every plan before anything is prescribed.
Our telehealth model serves Mandan and communities across North Dakota with the same flat pricing and the same supervising physician. We accept HSA, FSA, Klarna, and Affirm, with no mandatory membership and no surprise charges for Mandan patients.
GLP-1 Weight Loss Programs Available
Semaglutide (90-Day Metabolic Reset), from $166/mo
Our most popular program for Mandan patients uses semaglutide, the same active ingredient found in Wegovy® and Ozempic®. In clinical trials of the branded drug, patients lost an average of 15-17% of body weight, with physician oversight and monthly dose adjustments.
Tirzepatide (Advanced Program), from $233/mo · just $7.70/day
For maximum results, tirzepatide uses a dual GLP-1/GIP mechanism that clinical trials showed can reach up to 22.5% body-weight loss.
Doctor review: $119. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted.
How Telehealth Works for Mandan
First, you complete the online medical intake in a few minutes. Next, Dr. Sharma reviews your history by secure video, usually within 48 hours. If you are a candidate and telehealth-eligible, your compounded medication ships to your Mandan address in cold-pack packaging, and follow-ups and dose adjustments continue by video, with no travel.
Frequently Asked Questions, Mandan
How do I get treatment from Mandan?
As a Mandan, North Dakota patient you connect with our Costa Mesa, California clinic by telehealth. Dr. Sharma oversees your plan by secure video and compounded medication ships to your home; eligibility is confirmed during the consultation.
Can I do this without an in-person visit from Mandan?
Yes, it is fully telehealth. Your review, prescription, and follow-up are remote, with medication shipped to Mandan in cold-pack packaging, no lines and no drive.
How much does it cost for Mandan patients?
A $119 physician review, then compounded semaglutide from $166/month or tirzepatide from $233/month (medication separate). HSA, FSA, Klarna, and Affirm are accepted, and there is never a distance surcharge.
What areas of Mandan do you serve?
We serve patients from across Mandan by telehealth, including downtown Mandan and the Bismarck-Mandan metro on the Missouri River.
What does treatment cost for Mandan patients?
The same flat pricing nationwide: a $119 physician visit, compounded semaglutide from $166/month, and compounded tirzepatide from $233/month, with medication billed separately. HSA, FSA, Klarna, and Affirm are accepted, and there is no distance surcharge for Mandan.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Mandan, North Dakota by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.